Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing-Reference-Cited by-同舟云学术

Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing

Published:2019-03 Issue:3 Volume:152 Page:612-617
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fulk Kelly,Milam Michael R.,Li Shuwei,Yussuf Amal,Black Mary Helen,Chao Elizabeth C.,LaDuca Holly,Stany Michael P.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference31 articles.

1. Cancer Facts and Figures 2017;American Cancer Society,2017

2. Committee SGOCP. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions;Lancaster;Gynecol. Oncol.,2015

3. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility;de Jong;J. Med. Genet.,2002

4. Associations between cancer predisposition testing panel genes and breast cancer;Couch;JAMA Oncol.,2017

5. Hereditary syndromes manifesting as endometrial carcinoma: how can pathological features aid risk assessment?;Wong;Biomed. Res. Int.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape;Pharmaceuticals;2023-07-24

2. Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis;Archives of Gynecology and Obstetrics;2022-03-02

3. Case–case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer;Human Mutation;2021-07-21

4. Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development;Cancers;2021-04-07

5. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study;JNCI: Journal of the National Cancer Institute;2021-03-12